[
  {
    "ts": "2025-09-30T10:49:27+00:00",
    "headline": "NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing",
    "summary": "Lecanemab has secured approvals in 50 countries and is under review in 10 others.",
    "url": "https://www.pharmaceutical-technology.com/news/eisai-biogen-leqembi/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "467202d2-ebed-3a1d-9853-2b45a80c083b",
      "content": {
        "id": "467202d2-ebed-3a1d-9853-2b45a80c083b",
        "contentType": "STORY",
        "title": "NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing",
        "description": "",
        "summary": "Lecanemab has secured approvals in 50 countries and is under review in 10 others.",
        "pubDate": "2025-09-30T10:49:27Z",
        "displayTime": "2025-09-30T10:49:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/a3df75ba2849215b78f10bc1c821b0ce",
          "originalWidth": 1440,
          "originalHeight": 809,
          "caption": "Eisai secured worldwide rights for the development and marketing of the antibody for Alzheimer's disease treatment in an agreement with BioArctic in December 2007. Credit: David Gyung/Shutterstock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rsyTVhYkd8fl59eHEw0UOA--~B/aD04MDk7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/a3df75ba2849215b78f10bc1c821b0ce.cf.webp",
              "width": 1440,
              "height": 809,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QGMeIFteVo8DUfzxRvfdNg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/a3df75ba2849215b78f10bc1c821b0ce.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/eisai-biogen-leqembi/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nmpa-approves-eisai-biogen-leqembi-104927694.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "4523.T"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]